The impact of weight loss jabs on the food industry is a hot topic, and Greggs CEO, Roisin Currie, has shed light on the situation. 'There's no doubt that appetite-suppressing drugs have led to people seeking smaller portions,' Currie stated, emphasizing the effect on the company's sales. But here's where it gets interesting: while some businesses are adapting to this trend, others are capitalizing on it. 'People are also looking for protein and fibre, and generally healthier options,' Currie added, revealing Greggs' strategy to introduce products catering to this new market. This shift in consumer behavior has forced many companies to rethink their offerings. 'We've had to ensure we have some of the snack products that customers are looking for if they are on any of the GLP-1 drugs,' Currie explained. But is this a positive or negative development? And what does it mean for the future of food? These are the questions that many in the industry are asking. 'Clearly our strongest source of growth this year has been in fresh food,' said Tesco CEO Ken Murphy, highlighting the trend towards healthier eating. 'We also have a range of high-protein products across a number of different categories that also work very well in that context.' However, some argue that this shift is not solely due to weight loss drugs, but also to 'shrinkflation' - the practice of reducing portion sizes while keeping prices the same. 'Perhaps the clearest indication of the impact of glucagon-peptide (GLP) drugs upon the nation's eating habits?' asked consumer analyst Clive Black. As the food industry continues to evolve, one thing is certain: the impact of weight loss jabs on consumer behavior is here to stay. So, what do you think? Are you seeing these changes in your own grocery shopping? And what do you think about the future of food? Share your thoughts in the comments below!
